This article is an orphan, as no other articles link to it. Please introduce links to this page from related articles; try the Find link tool for suggestions. (October 2024) |
LFMD | |
Formerly | ImmuDyne, Inc. Conversion Labs, Inc. |
Company type | Public |
Industry | Telehealth |
Founded | May 24, 1994New York City, United States | in
Key people | Justin Schreiber, CEO Bobby Jindal, Board member[1] |
Website | lifemd |
Footnotes / references [2] |
LifeMD, Inc. is a publicly traded American telehealth company.[3] It gives subscribers access to doctors and nurse practitioners for virtual medical consultations and treatments with prescription medications.[4]
The company was founded as ImmuDyne, Inc. in 1994 and completed its initial public offering in 2001.[5] In 2018, it rebranded as Conversion Labs, Inc. with Justin Schreiber named chief executive officer.[6] The company changed its name to LifeMD in 2020 and started using the ticker name LFMD.[7][8]
In June 2023, LifeMD announced a weight management program to prescribe GLP-1 medications upon meeting requirements in a virtual appointment with a clinician.[9] It began a pilot program with Medifast, which later announced a partnership between the companies to connect each other's customers. LifeMD also received a $20 million investment from Medifast at that time.[10]
The company introduced private health insurance acceptance in 2024.[11]